Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients.
In: European Journal of Clinical Pharmacology, Jg. 62 (2006-10-01), Heft 10, S. 877-880
Online
academicJournal
Zugriff:
Eradication of Helicobacter pylori is an important treatment strategy in peptic ulcer patients. Current regimens of eradication consist of proton pump inhibitor (PPI) and two antibiotics. The principal enzyme involved in PPIs metabolism is CYP2C19, which exhibits an interindividual variability of activity, mainly due to genetic polymorphism. Two alleles ( CYP2C19*2 and CYP2C19*3), responsible for slow PPIs metabolism, were previously associated with higher efficacy of eradication. Recently, a novel CYP2C19 gene variant ( CYP2C19*17), associated with faster metabolism of CYP2C19 substrates, was described. In the present study, a potential association between CYP2C19*17 allele and lower H. pylori eradication efficacy was tested in a group of peptic ulcer patients. A total of 125 peptic ulcer patients, positive for H. pylori infection, were treated with triple therapy (pantoprazole+amoxicillin+metronidazole). Subsequently, the patients were divided into two groups (group 1 – success, and group 2 – failure of eradication after therapy) and genotyped for the presence of CYP2C19 variant alleles (*2, *3, and *17). Frequency of CYP2C19 alleles in two groups of patients were: 56.4 versus 65 ( p=0.060) for *1, 15.4 versus 5.3 ( p=0.015) for *2, and 28.2 versus 25.5 ( p=0.663) for *17 allele, respectively. CYP2C19*3 was not detected in the evaluated population. No significant differences in frequency nor distribution of *17 allele were found between two groups of patients. CYP2C19*2 allele was associated with successful H. pylori eradication ( p<0.02), *2 allele carriers were found to be over 4-times more prone to the treatment compared to *1/*1 homozygotes (OR=4.2, p=0.015). Our results suggest that, contrary to CYP2C19*2, CYP2C19*17 allele has no impact on efficacy of H. pylori eradication in peptic ulcer patients treated with pantoprazole. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Clinical Pharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients.
|
---|---|
Autor/in / Beteiligte Person: | Kurzawski, Mateusz ; Gawrońska-Szklarz, Barbara ; Wrześniewska, Joanna ; Siuda, Andrzej ; Starzyńska, Teresa ; Droździk, Marek |
Link: | |
Zeitschrift: | European Journal of Clinical Pharmacology, Jg. 62 (2006-10-01), Heft 10, S. 877-880 |
Veröffentlichung: | 2006 |
Medientyp: | academicJournal |
ISSN: | 0031-6970 (print) |
DOI: | 10.1007/s00228-006-0183-2 |
Schlagwort: |
|
Sonstiges: |
|